Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other Non-Current Assets (2021 - 2025)

Rxo's Other Non-Current Assets history spans 5 years, with the latest figure at $24.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 42.86% year-over-year to $24.0 million; the TTM value through Dec 2025 reached $24.0 million, down 42.86%, while the annual FY2025 figure was $24.0 million, 42.86% down from the prior year.
  • Other Non-Current Assets reached $24.0 million in Q4 2025 per RXO's latest filing, up from $23.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $42.0 million in Q4 2024 to a low of $12.0 million in Q4 2023.
  • Average Other Non-Current Assets over 5 years is $21.9 million, with a median of $16.0 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: surged 250.0% in 2024, then tumbled 42.86% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $16.0 million in 2021, then fell by 6.25% to $15.0 million in 2022, then decreased by 20.0% to $12.0 million in 2023, then soared by 250.0% to $42.0 million in 2024, then crashed by 42.86% to $24.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Other Non-Current Assets are $24.0 million (Q4 2025), $23.0 million (Q3 2025), and $31.0 million (Q2 2025).